Ovid Therapeutics Inc. (OVID) Shareholders’ equity 2020–2025
Ovid Therapeutics Inc. (OVID) shareholders’ equity at each fiscal year-end, per SEC filings.
$130.7MFY2025 · since FY2020: $43.6M → $130.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $130.7M | +91.5% |
| FY2024 | $68.2M | -22.3% |
| FY2023 | $87.8M | -33.6% |
| FY2022 | $132.3M | -26.4% |
| FY2021 | $179.7M | +312.0% |
| FY2020 | $43.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice